Glenmark Wants Out Of Pharmacies' Pay-For-Delay Lawsuits
Glenmark Pharmaceuticals wants out of an antitrust suit tied to the cholesterol drug Zetia, telling a Virginia federal judge that new claims accusing it of working up a three-way conspiracy with...To view the full article, register now.
Already a subscriber? Click here to view full article